Rockwell Medical Inc (RMTI)
Rockwell Medical, Inc. is a healthcare company focused on hemodialysis products for dialysis providers worldwide. Through its subsidiaries, the company develops, manufactures, commercializes, and distributes a range of dialysis-related concentrates and supporting supplies used in the dialysis process. Its product portfolio includes citric acid, acid concentrate, bicarbonate concentrate, and dry acid mixer products, along with ancillary items such as acetic acid, cleaners, descalers, and water softener salt pellets. Rockwell Medical says these products are used in hemodialysis to help remove toxins and balance electrolytes in a patient’s bloodstream. The company, formerly known as Rockwell Medical Technologies, Inc., adopted its current name in June 2012. Incorporated in 1996, Rockwell Medical is headquartered in Wixom, Michigan, and its common stock trades on the NASDAQ under the ticker RMTI.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-RMTI
|
$10.31
|
27.8% Upside
|
Undervalued
|
$20
|
148.0% Upside
|
Bargain
|
Good
|
0.0%
|
November 16, 2026
|
0.9x
|
0.5x
|
32.506 M
|
21.017 M
|
30.4%
|
88.9%
|
-9.6
|
-29.4%
|
